HomeMRSN • NASDAQ
add
Mersana Therapeutics Inc
Previous close
$7.47
Day range
$7.13 - $7.46
Year range
$5.21 - $70.73
Market cap
35.63M USD
Avg Volume
87.24K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 3.06M | 33.28% |
Operating expense | 7.42M | -29.40% |
Net income | -24.30M | -0.12% |
Net profit margin | -795.03 | 24.88% |
Earnings per share | -4.08 | 18.36% |
EBITDA | -20.29M | 19.01% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 76.97M | -52.70% |
Total assets | 84.57M | -52.79% |
Total liabilities | 137.72M | -19.32% |
Total equity | -53.15M | — |
Shares outstanding | 4.99M | — |
Price to book | -0.70 | — |
Return on assets | -52.21% | — |
Return on capital | 265.38% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -24.30M | -0.12% |
Cash from operations | -22.60M | -3.42% |
Cash from investing | 395.00K | -92.84% |
Cash from financing | -3.11M | -2,131.37% |
Net change in cash | -25.32M | -56.38% |
Free cash flow | -13.26M | -66.15% |
About
Founded
2001
Website
Employees
102
